Suppr超能文献

实施美国药典第797章——药物配制-无菌制剂,第5部分:配制制剂的准确性、无菌性和灭菌验证的注意事项。

Considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 5: verification of accuracy, sterility, and sterilization of compounded preparations.

作者信息

Allen Loyd V, Okeke Claudia C

机构信息

International Journal of Pharmaceutical Compounding, Edmond, Oklahoma.

出版信息

Int J Pharm Compd. 2008 Jan-Feb;12(1):54-60.

Abstract

United States Pharmacopeia Chapter 797 Pharmaceutical Compounding-Sterile Preparations pertains to all preadministration manipulations and procedures involved in the preparation of sterile compounds for application, implantation, infusion, inhalation, injection, insertion, instillation, or irrigation, including preparation, storage, and transportation. The chapter does not pertain to actual clinical administation of compounded sterile preparations to patients. The intent of Chapter 797 is simply to prevent patient harm and fatalitites that may result from nosterility, excessive endotoxin load, large content errors in strength of correct ingredients, or the presence of incorrect ingredients. Because the achievement of sterility requires that facilities meet minimum cleanliness standards, that personnel be trained adequately and undergo periodic testing and training in sterilization techniques, and that appropriate principles and practices be applied to sustain solution stablity, compliance with Chapter 797 should be the goal of any facility where sterile preparations are compounded. Many pharmacies have already achieved compliance with Chapter 797, and those that have already met the new standards seem to support them strongly. This article discusses procedures for verification of the accuracy, sterility, and sterilization of compounded preparations. The importance of United States Pharmacopeia Chapter 71, 1035, and 1211, all of which contain vital information, is also discussed.

摘要

《美国药典》第797章“药物配制 - 无菌制剂”适用于为应用、植入、输注、吸入、注射、插入、滴注或冲洗而制备无菌化合物所涉及的所有给药前操作和程序,包括制备、储存和运输。本章不适用于将配制好的无菌制剂实际临床给药给患者的情况。第797章的目的仅仅是防止因无菌性缺失、内毒素负荷过高、正确成分强度的含量误差过大或存在错误成分而可能导致的患者伤害和死亡。由于实现无菌要求设施符合最低清洁标准,人员接受充分培训并定期接受灭菌技术测试和培训,以及应用适当的原则和实践来维持溶液稳定性,因此遵守第797章应该是任何配制无菌制剂的机构的目标。许多药房已经实现了对第797章的遵守,而且那些已经符合新标准的药房似乎大力支持这些标准。本文讨论了验证配制制剂的准确性、无菌性和灭菌的程序。还讨论了《美国药典》第71章、1035章和1211章的重要性,所有这些章节都包含重要信息。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验